Mitochondrial genome stability in human: understanding the role of DNA repair pathways
Mitochondria are semiautonomous organelles in eukaryotic cells and possess their very own genome that replicates independently. Mitochondria play a significant function in oxidative phosphorylation on account of which its genome is often uncovered to oxidative stress. Components together with ionizing radiation, radiomimetic medication and replication fork stalling also can lead to several types of mutations in mitochondrial DNA (mtDNA) resulting in genome fragility.
Mitochondria from myopathies, dystonia, most cancers affected person samples present frequent mtDNA mutations reminiscent of level mutations, insertions and large-scale deletions that would account for mitochondria-associated illness pathogenesis. The mechanism by which such mutations come up following publicity to numerous DNA-damaging brokers isn’t nicely understood. One of many well-studied restore pathways in mitochondria is base excision restore.
Different restore pathways reminiscent of mismatch restore, homologous recombination and microhomology-mediated finish becoming a member of have additionally been reported. Curiously, nucleotide excision restore and classical nonhomologous DNA finish becoming a member of should not detected in mitochondria. On this assessment, we summarize the potential causes of mitochondrial genome fragility, their implications in addition to numerous DNA restore pathways that function in mitochondria.
Lack of Mitochondrial Protease CLPP Prompts Sort I IFN Responses via the Mitochondrial DNA-cGAS-STING Signaling Axis
Caseinolytic mitochondrial matrix peptidase proteolytic subunit (CLPP) is a serine protease that degrades broken or misfolded mitochondrial proteins. CLPP-null mice exhibit progress retardation, deafness, and sterility, resembling human Perrault syndrome, but additionally show immune system alterations. Nevertheless, the molecular mechanisms and signaling pathways underlying immunological modifications in CLPP-null mice stay unclear.
On this research, we report the steady-state activation of sort I IFN signaling and antiviral gene expression in CLPP-deficient cells and tissues, leading to marked resistance to RNA and DNA virus an infection. Depletion of the cyclic GMP-AMP (cGAS)-stimulator of IFN genes (STING) DNA sensing pathway reduces steady-state IFN-I signaling and abrogates the broad antiviral phenotype of CLPP-null cells. Furthermore, we report that CLPP deficiency results in mitochondrial DNA (mtDNA) instability and packaging alterations.
Pharmacological and genetic approaches to deplete mtDNA or inhibit cytosolic launch markedly scale back antiviral gene expression, implicating mtDNA stress as the driving force of IFN-I signaling in CLPP-null mice. Our work locations the cGAS-STING-IFN-I innate immune pathway downstream of CLPP and should have implications for understanding Perrault syndrome and different human ailments involving CLPP dysregulation.
Mitochondrial DNA from osteoarthritic sufferers drives purposeful impairment of mitochondrial exercise: a research on transmitochondrial cybrids
With the redefinition of osteoarthritis (OA) and the understanding that the joint behaves as an organ, OA is now thought of a systemic sickness with a low grade of power irritation. Mitochondrial dysfunction is nicely documented in OA and has the capability to change chondrocyte and synoviocyte perform. Transmitochondrial cybrids are steered as a helpful mobile mannequin to review mitochondrial biology in vitro, as they carry totally different mitochondrial variants with the identical nuclear background.
The purpose of this work was to review mitochondrial and metabolic perform of cybrids with mitochondrial DNA from wholesome (N) and OA donors. On this work, the authors exhibit that cybrids from OA sufferers behave otherwise from cybrids from N donors in a number of mitochondrial parameters. Moreover, OA cybrids behave equally to OA chondrocytes. These outcomes improve our understanding of the function of mitochondria within the degeneration strategy of OA and current cybrids as a helpful mannequin to review OA pathogenesis.
Mitochondrial DNA permits AIM2 inflammasome activation and hepatocyte pyroptosis in non-alcoholic fatty liver illness
Nonalcoholic fatty liver illness (NAFLD) is typified by accumulating extra liver triacylglycerol, irritation, and liver dysfunction. This research was aimed to analyze the function of mitochondrial DNA synthesis-induced activation of Absent in melanoma 2 (AIM2) inflammasome and pyroptosis in NAFLD. Mice had been raised on a high-fat food plan for 24 weeks to ascertain NAFLD fashions. F4/80 immunofluorescence was carried out to mirror the inflammatory response within the liver of mice. Western blot, ELISA, and immunofluorescence had been adopted to find out the expression of AIM2 inflammasome-related proteins and components.
EdU immunofluorescence was utilized for the examination of mitochondrial DNA expression and circulation cytometry for cell pyroptosis. Agarose gel electrophoresis was used to detect the integrity of extracted mouse mitochondrial DNA (mtDNA). The degrees of AIM2 inflammasome-related proteins within the liver and the degrees of IL-1β and IL-18 in serum had been elevated in high-fat diet-induced NAFLD mice. AIM2 inflammasome activation and pyroptosis had been triggered, and suppressed activation of AIM2 inflammasome alleviated the irritation and pyroptosis within the liver of NAFLD mice. Mitochondria had been severely broken and mtDNA was synthesized after NAFLD modeling.
Additional, mtDNA therapy may promote palmitate (PA)-induced activation of AIM2 inflammasome and pyroptosis. Furthermore, inhibition of IRF1 gene alleviated PA-induced AIM2 inflammasome activation and pyroptosis. In conclusion, mitochondrial DNA synthesis may allow AIM2 inflammasome activation and induce the hepatocyte pyroptosis, thereby exacerbating NAFLD.
Haplotypes traceability and genetic variability of the breeding inhabitants of pacu (Piaractus mesopotamicus) revealed by mitochondrial DNA
The principle goal of this research was to estimate the genetic range ranges and haplotype traceability in pacu Piaractus mesopotamicus from the breeding program positioned in Brazil by analyses of the mitochondrial DNA management area (mtDNA). Furthermore, broodstocks from eight business fish farms had been used for comparative analysis, 4 from Brazil (Br1-Br4) and 4 from Argentina (Ar1-Ar4). The descriptive outcomes revealed 47 polymorphic websites and 51 mutations, which evidenced 34 haplotypes. Ten haplotypes had been shared amongst fish farms and 24 had been unique.
The nucleotide range (π) ranged from 0.00031 to 0.01462 and haplotype range (Hd) from 0.125 to 0.868. The evaluation of molecular variance (AMOVA) indicated excessive construction current within the analyzed shares (FST = 0.13356 and ФST = 0.52707). The genetic range was excessive in a lot of the business broodstocks, particularly these from Brazil. We noticed seven haplotypes within the genetic breeding inhabitants, of which 4 had been unique and three shared among the many business fish farms.
Recombinant Acinetobacter lwoffii DNA gyrase subunit B (gyrB) |
|||
| MBS1467904-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1125 |
Recombinant Acinetobacter lwoffii DNA gyrase subunit B (gyrB) |
|||
| MBS1467904-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1200 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1299428-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1135 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1299428-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 720 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1299428-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 885 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1299428-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 865 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1299428-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1040 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1460882-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1135 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1460882-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 720 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1460882-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 885 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1460882-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 865 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1460882-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1040 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1459029-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1135 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1459029-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 720 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1459029-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 885 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1459029-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 865 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1459029-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1040 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1380280-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1135 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1380280-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 720 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1380280-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 885 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1380280-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 865 |
Recombinant Acinetobacter sp. DNA gyrase subunit B (gyrB) |
|||
| MBS1380280-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1040 |
Recombinant Acinetobacter junii DNA gyrase subunit B (gyrB) |
|||
| MBS1397505-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter junii DNA gyrase subunit B (gyrB) |
|||
| MBS1397505-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 930 |
Recombinant Acinetobacter junii DNA gyrase subunit B (gyrB) |
|||
| MBS1397505-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1050 |
Recombinant Acinetobacter junii DNA gyrase subunit B (gyrB) |
|||
| MBS1397505-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter junii DNA gyrase subunit B (gyrB) |
|||
| MBS1397505-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1195 |
Recombinant Acinetobacter baumannii DNA gyrase subunit B (gyrB) |
|||
| MBS1320636-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter baumannii DNA gyrase subunit B (gyrB) |
|||
| MBS1320636-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 930 |
Recombinant Acinetobacter baumannii DNA gyrase subunit B (gyrB) |
|||
| MBS1320636-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1050 |
Recombinant Acinetobacter baumannii DNA gyrase subunit B (gyrB) |
|||
| MBS1320636-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter baumannii DNA gyrase subunit B (gyrB) |
|||
| MBS1320636-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1195 |
Recombinant Acinetobacter johnsonii DNA gyrase subunit B (gyrB) |
|||
| MBS1379055-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter johnsonii DNA gyrase subunit B (gyrB) |
|||
| MBS1379055-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 935 |
Recombinant Acinetobacter johnsonii DNA gyrase subunit B (gyrB) |
|||
| MBS1379055-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1055 |
Recombinant Acinetobacter johnsonii DNA gyrase subunit B (gyrB) |
|||
| MBS1379055-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter johnsonii DNA gyrase subunit B (gyrB) |
|||
| MBS1379055-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1200 |
Recombinant Acinetobacter haemolyticus DNA gyrase subunit B (gyrB) |
|||
| MBS1286870-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter haemolyticus DNA gyrase subunit B (gyrB) |
|||
| MBS1286870-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 930 |
Recombinant Acinetobacter haemolyticus DNA gyrase subunit B (gyrB) |
|||
| MBS1286870-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1050 |
Recombinant Acinetobacter haemolyticus DNA gyrase subunit B (gyrB) |
|||
| MBS1286870-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter haemolyticus DNA gyrase subunit B (gyrB) |
|||
| MBS1286870-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1195 |
Recombinant Acinetobacter calcoaceticus DNA gyrase subunit B (gyrB) |
|||
| MBS1357084-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter calcoaceticus DNA gyrase subunit B (gyrB) |
|||
| MBS1357084-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 930 |
Recombinant Acinetobacter calcoaceticus DNA gyrase subunit B (gyrB) |
|||
| MBS1357084-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1050 |
Recombinant Acinetobacter calcoaceticus DNA gyrase subunit B (gyrB) |
|||
| MBS1357084-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter calcoaceticus DNA gyrase subunit B (gyrB) |
|||
| MBS1357084-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1195 |
Recombinant Acinetobacter genomosp. 3 DNA gyrase subunit B (gyrB) |
|||
| MBS1311457-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter genomosp. 3 DNA gyrase subunit B (gyrB) |
|||
| MBS1311457-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 930 |
Recombinant Acinetobacter genomosp. 3 DNA gyrase subunit B (gyrB) |
|||
| MBS1311457-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1050 |
Recombinant Acinetobacter genomosp. 3 DNA gyrase subunit B (gyrB) |
|||
| MBS1311457-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter genomosp. 3 DNA gyrase subunit B (gyrB) |
|||
| MBS1311457-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1195 |
Recombinant Acinetobacter genomosp. 11 DNA gyrase subunit B (gyrB) |
|||
| MBS1439539-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter genomosp. 11 DNA gyrase subunit B (gyrB) |
|||
| MBS1439539-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 935 |
Recombinant Acinetobacter genomosp. 11 DNA gyrase subunit B (gyrB) |
|||
| MBS1439539-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1055 |
Recombinant Acinetobacter genomosp. 11 DNA gyrase subunit B (gyrB) |
|||
| MBS1439539-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter genomosp. 11 DNA gyrase subunit B (gyrB) |
|||
| MBS1439539-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1200 |
Recombinant Acinetobacter genomosp. 10 DNA gyrase subunit B (gyrB) |
|||
| MBS1381201-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1135 |
Recombinant Acinetobacter genomosp. 10 DNA gyrase subunit B (gyrB) |
|||
| MBS1381201-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 720 |
Recombinant Acinetobacter genomosp. 10 DNA gyrase subunit B (gyrB) |
|||
| MBS1381201-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 885 |
Recombinant Acinetobacter genomosp. 10 DNA gyrase subunit B (gyrB) |
|||
| MBS1381201-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 865 |
Recombinant Acinetobacter genomosp. 10 DNA gyrase subunit B (gyrB) |
|||
| MBS1381201-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1040 |
Recombinant Acinetobacter genomosp. 6 DNA gyrase subunit B (gyrB) |
|||
| MBS1360828-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter genomosp. 6 DNA gyrase subunit B (gyrB) |
|||
| MBS1360828-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 930 |
Recombinant Acinetobacter genomosp. 6 DNA gyrase subunit B (gyrB) |
|||
| MBS1360828-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1050 |
Recombinant Acinetobacter genomosp. 6 DNA gyrase subunit B (gyrB) |
|||
| MBS1360828-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1120 |
Recombinant Acinetobacter genomosp. 6 DNA gyrase subunit B (gyrB) |
|||
| MBS1360828-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1195 |
Recombinant Acinetobacter lwoffii Esterase (est) |
|||
| MBS1068205-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1180 |
Recombinant Acinetobacter lwoffii Esterase (est) |
|||
| MBS1068205-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 830 |
Recombinant Acinetobacter lwoffii Esterase (est) |
|||
| MBS1068205-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 970 |
Recombinant Acinetobacter lwoffii Esterase (est) |
|||
| MBS1068205-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 990 |
Recombinant Acinetobacter lwoffii Esterase (est) |
|||
| MBS1068205-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1140 |
Recombinant Acinetobacter lwoffii Lipase chaperone (lifO), partial |
|||
| MBS7102859-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 1 (catA1) |
|||
| MBS1014662-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1190 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 1 (catA1) |
|||
| MBS1014662-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 835 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 1 (catA1) |
|||
| MBS1014662-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 980 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 1 (catA1) |
|||
| MBS1014662-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1005 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 1 (catA1) |
|||
| MBS1014662-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1120 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 2 (catA2) |
|||
| MBS1132798-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1155 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 2 (catA2) |
|||
| MBS1132798-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 795 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 2 (catA2) |
|||
| MBS1132798-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 945 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 2 (catA2) |
|||
| MBS1132798-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 950 |
Recombinant Acinetobacter lwoffii Catechol 1,2-dioxygenase 2 (catA2) |
|||
| MBS1132798-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1105 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-2 (catB2) |
|||
| MBS1144090-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1260 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-2 (catB2) |
|||
| MBS1144090-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 925 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-2 (catB2) |
|||
| MBS1144090-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1050 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-2 (catB2) |
|||
| MBS1144090-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1115 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-2 (catB2) |
|||
| MBS1144090-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1195 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-1 (catB1) |
|||
| MBS1036600-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1250 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-1 (catB1) |
|||
| MBS1036600-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 920 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-1 (catB1) |
|||
| MBS1036600-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 1045 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-1 (catB1) |
|||
| MBS1036600-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1105 |
Recombinant Acinetobacter lwoffii Muconate cycloisomerase 1-1 (catB1) |
|||
| MBS1036600-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1190 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 2 (catC2) |
|||
| MBS1073663-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1020 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 2 (catC2) |
|||
| MBS1073663-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 590 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 2 (catC2) |
|||
| MBS1073663-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 775 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 2 (catC2) |
|||
| MBS1073663-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 700 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 2 (catC2) |
|||
| MBS1073663-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 905 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 1 (catC1) |
|||
| MBS1218927-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1020 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 1 (catC1) |
|||
| MBS1218927-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 590 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 1 (catC1) |
|||
| MBS1218927-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 775 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 1 (catC1) |
|||
| MBS1218927-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 700 |
Recombinant Acinetobacter lwoffii Muconolactone Delta-isomerase 1 (catC1) |
|||
| MBS1218927-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 905 |
Recombinant Acinetobacter lwoffii Probable cat1 operon transcriptional activator |
|||
| MBS1154074-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1180 |
Recombinant Acinetobacter lwoffii Probable cat1 operon transcriptional activator |
|||
| MBS1154074-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 830 |
Recombinant Acinetobacter lwoffii Probable cat1 operon transcriptional activator |
|||
| MBS1154074-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 970 |
Recombinant Acinetobacter lwoffii Probable cat1 operon transcriptional activator |
|||
| MBS1154074-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 990 |
Recombinant Acinetobacter lwoffii Probable cat1 operon transcriptional activator |
|||
| MBS1154074-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1140 |
Recombinant Acinetobacter sp. DNA gyrase inhibitor YacG (yacG) |
|||
| MBS1414621-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Acinetobacter sp. DNA gyrase inhibitor YacG (yacG) |
|||
| MBS1414621-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Acinetobacter sp. DNA gyrase inhibitor YacG (yacG) |
|||
| MBS1414621-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Acinetobacter sp. DNA gyrase inhibitor YacG (yacG) |
|||
| MBS1414621-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Acinetobacter sp. DNA gyrase inhibitor YacG (yacG) |
|||
| MBS1414621-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Acinetobacter baumannii ATP synthase subunit b (atpF) |
|||
| MBS1120795-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Acinetobacter baumannii ATP synthase subunit b (atpF) |
|||
| MBS1109186-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Acinetobacter baumannii ATP synthase subunit b (atpF) |
|||
| MBS1108512-INQUIRE | MyBiosource | INQUIRE | Ask for price |
The genetic range was average (π = 0.00265 and Hd = 0.424) and regarded appropriated for this breeding inhabitants of pacu. Our outcomes present help for the genetic range upkeep and mtDNA traceability of pacu business broodstocks.
